MicroRNA-181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib

MicroRNA-181 (miR-181) has been recently demonstrated to participate in the differentiation and development of immune cells, including natural killer cells and B and T lymphocytes, and myeloid linages, including erythroid and megakaryocytic cells. The aberrant expression of miR-181, particularly low...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncol Lett
Glavni autori: WANG, GUANGYU, ZHAO, RAN, ZHAO, XINGSHENG, CHEN, XI, WANG, DONG, JIN, YINJI, LIU, XI, ZHAO, CI, ZHU, YUANYUAN, REN, CHENGCHENG, LI, MINGHUI, JIN, XIAOMING, ZHANG, FENGMIN, ZHONG, ZHAOHUA, WANG, TIANZHEN, LI, XIAOBO
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2015
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4665220/
https://ncbi.nlm.nih.gov/pubmed/26722250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3663
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items